Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AZN AstraZeneca	$68.79 -0.7%	$70.78	$61.24 ▼ $87.68	$213.34B	0.37	5.29 million shs	2.99 million shs
AZN AstraZeneca	$68.79 -0.7%	$70.78	$61.24 ▼ $87.68	$213.34B	0.37	5.29 million shs	2.99 million shs
AZNCF AstraZeneca	$142.02	$141.93	$120.64 ▼ $175.00	N/A	N/A	2,174 shs	232 shs
DOW DOW	$28.34 -0.4%	$28.77	$25.06 ▼ $55.67	$20.03B	0.89	7.70 million shs	9.01 million shs
SWY Safeway		$0.00	$29.82 ▼ $40.25	N/A	N/A	4.06 million shs	N/A
TSLA Tesla	$329.65 +3.2%	$326.27	$182.00 ▼ $488.54	$1.06T	2.39	98.93 million shs	93.90 million shs
WBA Walgreens Boots Alliance	$11.49 -0.2%	$11.36	$8.08 ▼ $13.25	$9.95B	0.78	18.82 million shs	5.21 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AZN AstraZeneca	0.00%	-3.29%	-2.78%	+1.85%	-13.75%
AZN AstraZeneca	0.00%	-3.29%	-2.78%	+1.85%	-13.75%
AZNCF AstraZeneca	0.00%	+1.25%	-1.10%	+1.59%	-9.07%
DOW DOW	0.00%	-4.09%	-0.65%	+0.78%	-48.86%
TSLA Tesla	0.00%	+5.15%	+2.36%	+36.69%	+32.66%
WBA Walgreens Boots Alliance	0.00%	-0.26%	+0.88%	+5.51%	-3.04%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AZN AstraZeneca	4.0459 of 5 stars	3.4	5.0	1.7	0.0	3.9	0.0	1.9
AZN AstraZeneca	4.0459 of 5 stars	3.4	5.0	1.7	0.0	3.9	0.0	1.9
AZNCF AstraZeneca	0.1067 of 5 stars	0.0	0.0	1.7	0.0	1.1	0.8	0.0
DOW DOW	3.3962 of 5 stars	3.0	2.0	1.7	0.0	1.9	1.7	2.5
SWY Safeway	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	4.6788 of 5 stars	2.1	5.0	0.0	3.5	3.1	5.0	1.9
WBA Walgreens Boots Alliance	2.2122 of 5 stars	0.9	2.0	0.0	2.3	2.1	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AZN AstraZeneca	2.83	Moderate Buy	$89.00	29.38% Upside
AZN AstraZeneca	2.83	Moderate Buy	$89.00	29.38% Upside
AZNCF AstraZeneca	0.00	N/A	N/A	N/A
DOW DOW	2.06	Hold	$33.47	18.10% Upside
SWY Safeway	0.00	N/A	N/A	N/A
TSLA Tesla	2.24	Hold	$300.19	-8.94% Downside
WBA Walgreens Boots Alliance	1.83	Reduce	$10.59	-7.82% Downside

Current Analyst Ratings Breakdown

Latest AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	TSLA Tesla	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$315.00 ➝ $285.00
7/9/2025	AZN AstraZeneca	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$97.00
7/9/2025	AZN AstraZeneca	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$97.00
7/9/2025	DOW DOW	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$28.00 ➝ $26.00
7/8/2025	DOW DOW	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$30.00 ➝ $28.00
7/8/2025	TSLA Tesla	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$390.00 ➝ $375.00
7/8/2025	TSLA Tesla	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell ➝ Sell	$175.00
7/8/2025	TSLA Tesla	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$500.00
7/7/2025	TSLA Tesla	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
7/3/2025	DOW DOW	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$32.00 ➝ $30.00
7/3/2025	TSLA Tesla	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$285.00 ➝ $315.00

(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AZN AstraZeneca	$54.07B	3.95	$6.29 per share	10.93	$13.18 per share	5.22
AZN AstraZeneca	$54.07B	3.95	$6.29 per share	10.93	$13.18 per share	5.22
AZNCF AstraZeneca	N/A	N/A	N/A	N/A	N/A	N/A
DOW DOW	$42.96B	0.47	$5.83 per share	4.86	$25.36 per share	1.12
SWY Safeway	N/A	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	$97.69B	10.87	$3.87 per share	85.11	$22.89 per share	14.40
WBA Walgreens Boots Alliance	$147.66B	0.07	$5.75 per share	2.00	$13.91 per share	0.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AZN AstraZeneca	$7.04B	$2.49	27.63	13.76	1.26	14.14%	33.14%	12.83%	7/29/2025 (Estimated)
AZN AstraZeneca	$7.04B	$2.49	27.63	13.76	1.26	14.14%	33.14%	12.83%	7/29/2025 (Estimated)
AZNCF AstraZeneca	N/A	$0.82	174.04	∞	N/A	N/A	N/A	N/A	7/29/2025 (Estimated)
DOW DOW	$1.12B	$0.40	70.85	9.74	11.18	0.69%	4.59%	1.44%	7/24/2025 (Estimated)
SWY Safeway	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	$7.13B	$1.82	181.13	97.24	12.56	6.66%	9.02%	5.39%	7/23/2025 (Estimated)
WBA Walgreens Boots Alliance	-$8.64B	-$7.29	N/A	7.87	1.35	-4.07%	17.66%	2.22%	N/A

Latest AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/29/2025	Q2 2025	AZN AstraZeneca	$1.11	N/A	N/A	N/A	$14.08 billion	N/A
7/29/2025	Q2 2025	AZN AstraZeneca	$1.11	N/A	N/A	N/A	$14.08 billion	N/A
7/24/2025	Q2 2025	DOW DOW	-$0.01	N/A	N/A	N/A	$10.38 billion	N/A
7/23/2025	Q2 2025	TSLA Tesla	$0.43	N/A	N/A	N/A	$23.18 billion	N/A
6/26/2025	Q3 2025	WBA Walgreens Boots Alliance	$0.34	$0.38	+$0.04	-$0.20	$36.72 billion	$38.99 billion
4/29/2025	Q1 2025	AZN AstraZeneca	$1.10	$1.24	+$0.14	$0.93	$13.71 billion	$13.59 billion
4/29/2025	Q1 2025	AZN AstraZeneca	$1.10	$1.24	+$0.14	$0.93	$13.71 billion	$13.59 billion
4/24/2025	Q1 2025	DOW DOW	-$0.01	$0.02	+$0.03	-$0.44	$10.31 billion	$10.43 billion
4/22/2025	Q1 2025	TSLA Tesla	$0.53	$0.27	-$0.26	$0.12	$22.93 billion	$19.34 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AZN AstraZeneca	$2.06	2.99%	N/A	82.73%	N/A
AZN AstraZeneca	$2.06	2.99%	N/A	82.73%	N/A
AZNCF AstraZeneca	$2.80	1.97%	N/A	343.14%	N/A
DOW DOW	$2.80	9.88%	N/A	700.00%	N/A
SWY Safeway	N/A	N/A	N/A	N/A	N/A
TSLA Tesla	N/A	N/A	N/A	N/A	N/A
WBA Walgreens Boots Alliance	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AZN AstraZeneca	0.65	0.90	0.70
AZN AstraZeneca	0.65	0.90	0.70
AZNCF AstraZeneca	N/A	N/A	N/A
DOW DOW	0.92	1.54	0.90
SWY Safeway	N/A	N/A	N/A
TSLA Tesla	0.07	2.00	1.54
WBA Walgreens Boots Alliance	0.96	0.60	0.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AZN AstraZeneca	20.35%
AZN AstraZeneca	20.35%
AZNCF AstraZeneca	40.87%
DOW DOW	64.00%
SWY Safeway	N/A
TSLA Tesla	66.20%
WBA Walgreens Boots Alliance	58.59%

Insider Ownership

Company	Insider Ownership
AZN AstraZeneca	N/A
AZN AstraZeneca	N/A
AZNCF AstraZeneca	N/A
DOW DOW	0.50%
SWY Safeway	N/A
TSLA Tesla	20.70%
WBA Walgreens Boots Alliance	17.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AZN AstraZeneca	94,300	3.10 billion	N/A	Optionable
AZN AstraZeneca	94,300	3.10 billion	N/A	Optionable
AZNCF AstraZeneca	83,500	N/A	N/A	Not Optionable
DOW DOW	36,000	706.86 million	703.33 million	Optionable
SWY Safeway	N/A	N/A	N/A	Not Optionable
TSLA Tesla	125,665	3.22 billion	2.55 billion	Optionable
WBA Walgreens Boots Alliance	312,000	865.56 million	714.09 million	Optionable

AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Headlines

Recent News About These Companies

Float or flog: What does future hold for ‘unloved’ Boots under new owners?

July 18 at 6:04 PM | retailgazette.co.ukR

168,400 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Tabor Asset Management LP

July 18 at 10:41 AM | marketbeat.com

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives $10.59 Consensus Price Target from Brokerages

July 18 at 2:37 AM | americanbankingnews.com

Wealthfront Advisers LLC Sells 648,521 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

July 17 at 6:08 AM | marketbeat.com

Herbalife (NYSE:HLF) vs. Walgreens Boots Alliance (NASDAQ:WBA) Head-To-Head Contrast

July 17 at 4:11 AM | americanbankingnews.com

Kintayl Capital LP Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

July 16, 2025 | marketbeat.com

Premier Medical Collaborates with Walgreens to Expand Access to Care Across Central Florida

July 16, 2025 | businesswire.com

Nisa Investment Advisors LLC Raises Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

July 16, 2025 | marketbeat.com

Boots shareholders approve $10bn takeover deal

July 15, 2025 | retailgazette.co.ukR

Shareholders approve Walgreens sale to Sycamore Partners

July 15, 2025 | healthcarefinancenews.comH

Boots shareholders approve $10 billion Sycamore Partners takeover deal

July 15, 2025 | cosmeticsbusiness.comC

Third time lucky? Boots faces sale speculation after £7.4bn Walgreens buyout

July 15, 2025 | thebusinessdesk.comT

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives Consensus Recommendation of "Reduce" from Brokerages

July 15, 2025 | marketbeat.com

Walgreens acquisition by Sycamore wins shareholder agreement

July 14, 2025 | finance.yahoo.com

Walgreens Takes Major Step Toward Becoming Private Company Again

July 14, 2025 | forbes.com

Walgreens Boots Alliance Shareholders Approve Sycamore Partners Acquisition Deal

July 14, 2025 | globalcosmeticsnews.comG

$10 Billion Exit: Walgreens Just Got Bought Out

July 13, 2025 | gurufocus.com

Teacher Retirement System of Texas Acquires Shares of 107,377 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

July 13, 2025 | marketbeat.com

Walgreens Boots Alliance shareholders approve transaction with Sycamore

July 12, 2025 | finance.yahoo.com

M&T Bank Corp Boosts Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

July 12, 2025 | marketbeat.com

Bank of New York Mellon Corp Purchases 212,997 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

July 12, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Stocks to Buy Ahead of the Upcoming Earnings Season
By Chris Markoch | July 11, 2025
View 3 Stocks to Buy Ahead of the Upcoming Earnings Season
Addition by Subtraction: Intel’s New Strategy Energizes Investors
By Jeffrey Neal Johnson | June 27, 2025
View Addition by Subtraction: Intel’s New Strategy Energizes Investors
Dollar Down 10%? These 3 Stocks Could Soar
By Chris Markoch | July 1, 2025
View Dollar Down 10%? These 3 Stocks Could Soar
Costco at a Crossroads: Is the Next Move Higher or Lower?
By Dan Schmidt | June 25, 2025
View Costco at a Crossroads: Is the Next Move Higher or Lower?
Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential
By Leo Miller | July 11, 2025
View Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential

AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Company Descriptions

AstraZeneca NASDAQ:AZN

$68.79 -0.47 (-0.68%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$68.80 +0.01 (+0.01%)

As of 07/18/2025 07:57 PM Eastern

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca NASDAQ:AZN

$68.79 -0.47 (-0.68%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$68.80 +0.01 (+0.01%)

As of 07/18/2025 07:57 PM Eastern

AstraZeneca OTCMKTS:AZNCF

$142.02 0.00 (0.00%)

As of 07/18/2025

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

DOW NYSE:DOW

$28.34 -0.12 (-0.42%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$28.41 +0.07 (+0.25%)

As of 07/18/2025 07:59 PM Eastern

Dow, Inc. is a materials science company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes and construction chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Safeway NYSE:SWY

Safeway Inc., is an food and drug retail company. The Company owns and operates GroceryWorks.com Operating Company, LLC, an online grocery channel doing business under the names Safeway.com and Vons.com. Blackhawk, a majority-owned subsidiary of Safeway, is a prepaid payment network utilizing proprietary technology to offer gift cards, other prepaid products and payment services. Blackhawk's payment network supports its three primary constituents: consumers who purchase the products and services Blackhawk offers, content providers who offer branded products that are redeemable for goods and services, and distribution partners who sell the products. Blackhawk's product offerings include gift cards, prepaid telecom products and prepaid financial services products, including general purpose reloadable cards and Blackhawk's reload network.

Tesla NASDAQ:TSLA

$329.65 +10.24 (+3.21%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$329.62 -0.02 (-0.01%)

As of 07/18/2025 08:00 PM Eastern

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.

Walgreens Boots Alliance NASDAQ:WBA

$11.49 -0.02 (-0.17%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$11.48 -0.01 (-0.04%)

As of 07/18/2025 07:58 PM Eastern

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AZN, AZNCF, AZN, DOW, SWY, TSLA, and WBA Company Descriptions

AstraZeneca NASDAQ:AZN

AstraZeneca NASDAQ:AZN

AstraZeneca OTCMKTS:AZNCF

DOW NYSE:DOW

Safeway NYSE:SWY

Tesla NASDAQ:TSLA

Walgreens Boots Alliance NASDAQ:WBA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools